4.7 Article

Combined IFN-γ-Endostatin Gene Therapy and Radiotherapy Attenuates Primary Breast Tumor Growth and Lung Metastases via Enhanced CTL and NK Cell Activation and Attenuated Tumor Angiogenesis in a Murine Model

Journal

ANNALS OF SURGICAL ONCOLOGY
Volume 16, Issue 5, Pages 1403-1411

Publisher

SPRINGER
DOI: 10.1245/s10434-009-0343-6

Keywords

-

Ask authors/readers for more resources

Gene-radiotherapy, a combination of gene therapy and radiotherapy, is a new paradigm for cancer treatment, with the potential to simultaneously improve local and systemic breast cancer control. The aim of this study was to evaluate antitumor effect of interferon (IFN)-gamma-endostatin-based gene-radiotherapy in a murine metastatic breast tumor model, and to elucidate possible mechanisms involved. Murine mammary adenocarcinoma 4T1 cells transfected with pEgr-IFN-gamma and pEgr-endostatin plasmids were irradiated (2-20 Gy). IFN-gamma and endostatin levels in the culture supernatants were measured. In vivo female BALB/c mice were inoculated with 1 x 10(5) 4T1 cells by mammary fat pad injection and divided into control, empty vector, gene therapy (pEgr-IFN-gamma and pEgr-endostatin), radiotherapy, and combined gene-radiotherapy groups. Tumor growth, tumor/body weight ratio, lung metastases, and survival of the tumor-bearing mice were observed. Splenic cytotoxic T-lymphocyte (CTL) and natural killer (NK) cell activity and intratumor microvessel density were also assessed. Irradiation significantly enhanced IFN-gamma and endostatin secretion from the transfected 4T1 cells. In vivo mice that received combined gene-radiotherapy showed maximal attenuation in tumor growth rate and lung metastases with increased survival compared with mice that received gene therapy or radiotherapy alone. This was associated with significantly enhanced CTL and NK cell activity and reduced intratumor microvessel density. These results demonstrate that IFN-gamma-endostatin-based gene-radiotherapy provide a potent antitumor effect in a murine metastatic breast tumor model, which may relate to IFN-gamma-stimulated CTL and NK cell activation, and endostatin-induced antiangiogenic activity. Thus, gene-radiotherapy may represent a useful addition to neoadjuvant management of locally advanced breast cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Approach to screening for Familial Adenomatous Polyposis (FAP) in a cohort of 226 patients with Desmoid-type Fibromatosis (DF): experience of a specialist center in the UK

E. Cojocaru, S. Gennatas, K. Thway, C. Fisher, A. Smrke, D. Strauss, A. Hayes, M. Smith, R. L. Jones, C. Benson, T. P. McVeigh

Summary: Desmoid-type fibromatosis (DF) is a locally infiltrative, non-metastasizing tumor associated with significant morbidity and mortality, mostly due to somatic CTNNB1 mutations. Alternatively, they can be associated with germline pathogenic variants in APC causing Familial Adenomatous Polyposis (FAP). CTNNB1 molecular testing is important for all newly diagnosed DF cases to determine treatment strategies.

FAMILIAL CANCER (2022)

Review Oncology

KIT Exon 9-Mutated Gastrointestinal Stromal Tumours: Biology and Treatment

Andrea Napolitano, Khin Thway, Myles J. Smith, Paul H. Huang, Robin L. Jones

Summary: Exon 9-mutant GISTs represent a distinct subtype of GISTs that differ from other GIST subtypes, including the more common KIT exon 11-mutant GISTs. A better understanding of the molecular biology and clinical behavior of exon 9-mutant GISTs may help identify more improved treatment options.

CHEMOTHERAPY (2022)

Article Oncology

Outcome after treatment for sebaceous carcinoma: A multicenter study

Eva Huis In 't Veld, Ronald Keizer, Nicoline Post, Jeroen Versteeg, Robert Verdijk, Nicole Naus, Germaine Relyveld, Marianne Crijns, Myles Smith, Dirk Grunhagen, Marlies Wakkee, Dion Paridaens, Ioannis Zavrakidis, Antien Mooyaart, Alexander van Akkooi, Dirk Strauss, Cornelis Verhoef, Michel Wouters, Andrew Hayes, Winan van Houdt

Summary: This study assessed the outcome of patients treated with resection for sebaceous carcinoma (SC) and found that SC is a rare tumor with low recurrence and metastasis rates. However, (peri)ocular SC and positive resection margins are associated with a higher risk of recurrence. These findings are important for understanding the development and treatment of SC.

JOURNAL OF SURGICAL ONCOLOGY (2022)

Editorial Material Oncology

ASO Visual Abstract: Frailty in Very Elderly Patients is not Associated with Adverse Surgical or Oncological Outcomes in Extremity Surgery for Soft Tissue Sarcoma

Gausihi Sivarajah, Emma Davies, Anna Hurley, Dirk C. Strauss, Myles J. F. Smith, Andrew J. Hayes

ANNALS OF SURGICAL ONCOLOGY (2022)

Article Oncology

The role of perioperative chemotherapy in primary high- grade extremity soft tissue sarcoma: a risk-stratified analysis using PERSARC

Ibtissam Acem, Winan J. van Houdt, Dirk J. Grunhagen, Winette T. A. van der Graaf, Anja J. Rueten-Budde, Hans Gelderblom, Cornelis Verhoef, Michiel A. J. van de Sande

Summary: This study aimed to assess the effect of perioperative chemo-therapy (CTX) on overall survival (OS) in patients with extremity soft tissue sarcoma (eSTS) and evaluate the predictive value of the PERSARC tool. The results showed that AI-based CTX was significantly associated with improved 5-year OS in high-risk patients, but no beneficial effect of CTX on OS was found in the overall population of patients with primary high-grade eSTS younger than 70 years.

EUROPEAN JOURNAL OF CANCER (2022)

Review Oncology

Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group

William W. Tseng, Carol J. Swallow, Dirk C. Strauss, Sylvie Bonvalot, Piotr Rutkowski, Samuel J. Ford, Ricardo J. Gonzalez, Rebecca A. Gladdy, David E. Gyorki, Mark Fairweather, Kyo Won Lee, Markus Albertsmeier, Winan J. van Houdt, Magalie Fau, Carolyn Nessim, Giovanni Grignani, Kenneth Cardona, Vittorio Quagliuolo, Valerie Grignol, Jeffrey M. Farma, Elisabetta Pennacchioli, Marco Fiore, Andrew Hayes, Dimitri Tzanis, Jacek Skoczylas, Max L. Almond, John E. Mullinax, Wendy Johnston, Hayden Snow, Rick L. Haas, Dario Callegaro, Myles J. Smith, Toufik Bouhadiba, Anant Desai, Rachel Voss, Roberta Sanfilippo, Robin L. Jones, Elizabeth H. Baldini, Andrew J. Wagner, Charles N. Catton, Silvia Stacchiotti, Khin Thway, Christina L. Roland, Chandrajit P. Raut, Alessandro Gronchi

Summary: This article summarizes the treatment consensus for locally recurrent retroperitoneal sarcoma (RPS). Resection surgery is found to be safe in appropriately selected patients, and combined with new findings and expert recommendations, 36 evidence-based and recommended statements are provided. The updated document emphasizes the histologic type and intention of surgical treatment. The fundamental principle for optimal care of patients with recurrent RPS remains individualized treatment after multidisciplinary discussion by an experienced team.

ANNALS OF SURGICAL ONCOLOGY (2022)

Review Oncology

Desmoid tumors: who, when and how to treat?

Rabih Mikhael, Myles Smith, Dimitri Tzanis, Sarah Watson, Aisha B. Miah, Sylvie Bonvalot

Summary: The purpose of this article is to provide a summary of the latest treatment strategies for desmoid tumors. Recent findings suggest that desmoid tumors can have an unpredictable evolution, and experts now recommend an initial strategy of active surveillance. Medical treatment is recommended when there is significant tumor growth or symptoms. Kinase inhibitors and cytotoxic agents have shown promising results in progressive desmoid tumors. Cryotherapy is an alternative option for tumors in suitable locations and sizes. Surgery is recommended for superficial sites with continuous progression after medical treatment or cryotherapy failure. Radiotherapy is an effective option when surgery is not feasible or would be mutilating. Active surveillance with planned imaging is now considered the first-line management for desmoid tumors.

CURRENT OPINION IN ONCOLOGY (2022)

Article Oncology

Ripretinib in advanced gastrointestinal stromal tumors: an overview of current evidence and drug approval

Caitriona Goggin, Anna Stansfeld, Preethika Mahalingam, Khin Thway, Myles J. Smith, Paul Huang, Robin L. Jones, Andrea Napolitano

Summary: The management of gastrointestinal stromal tumors has played a crucial role in advancing targeted therapies for solid tumors. Imatinib has been a successful first-line therapy, but the development of resistance necessitates the use of other treatments. Ripretinib is a switch-control tyrosine kinase inhibitor that specifically targets resistance mutations, and its molecular rationale and clinical use are discussed in this article.

FUTURE ONCOLOGY (2022)

Article Health Care Sciences & Services

A Delphi consensus statement for digital surgery

Kyle Lam, Michael D. Abramoff, Jose M. Balibrea, Steven M. Bishop, Richard R. Brady, Rachael A. Callcut, Manish Chand, Justin W. Collins, Markus K. Diener, Matthias Eisenmann, Kelly Fermont, Manoel Galvao Neto, Gregory D. Hager, Robert J. Hinchliffe, Alan Horgan, Pierre Jannin, Alexander Langerman, Kartik Logishetty, Amit Mahadik, Lena Maier-Hein, Esteban Martin Antona, Pietro Mascagni, Ryan K. Mathew, Beat P. Muller-Stich, Thomas Neumuth, Felix Nickel, Adrian Park, Gianluca Pellino, Frank Rudzicz, Sam Shah, Mark Slack, Myles J. Smith, Naeem Soomro, Stefanie Speidel, Danail Stoyanov, Henry S. Tilney, Martin Wagner, Ara Darzi, James M. Kinross, Sanjay Purkayastha

Summary: The use of digital technology in surgical specialties is growing rapidly, but there is no consensus on the term 'digital surgery'. Surgeons and patients face unique technical, governance, and legal challenges in the application of digital health technologies, highlighting the importance of addressing ethical issues in digital surgery.

NPJ DIGITAL MEDICINE (2022)

Letter Oncology

Letter to the Editor Regarding An Evidence-Based Staging System for Mucosal Melanoma: A Proposal

Henry G. Smith, Kevin J. Harrington, Myles J. F. Smith

ANNALS OF SURGICAL ONCOLOGY (2022)

Article Oncology

Prognosis of Patients with Cutaneous Angiosarcoma After Surgical Resection with Curative Intent: Is There a Difference Between the Subtypes?

Sophie J. M. Reijers, Eva A. Huis In 't Veld, Dirk J. Grunhagen, Myles J. F. Smith, Tessa M. van Ginhoven, Frits van Coevorden, Winette T. A. van der Graaf, Yvonne Schrage, Dirk C. Strauss, Rick L. M. Haas, Cornelis J. Verhoef, Andrew J. Hayes, Winan J. van Houdt

Summary: This study evaluated the oncological outcomes of different subtypes of cutaneous angiosarcoma (cAS). The results showed no significant differences between the subtypes in terms of recurrence, distant metastases, and overall survival. The study also found that radiotherapy was associated with lower recurrence rates.

ANNALS OF SURGICAL ONCOLOGY (2023)

Editorial Material Oncology

ASO Visual Abstract: Prognosis of Patients with Cutaneous Angiosarcoma After Surgical Resection with Curative Intent-Is There a Difference Between the Subtypes

Sophie J. M. Reijers, Eva A. Huis In't Veld, Dirk J. Grunhagen, Myles J. F. Smith, Tessa M. van Ginhoven, Frits van Coevorden, Winette T. A. van der Graaf, Yvonne Schrage, Dirk C. Strauss, Rick L. M. Haas, Cornelis J. Verhoef, Andrew J. Hayes, Winan J. van Houdt

ANNALS OF SURGICAL ONCOLOGY (2023)

Article Surgery

Worldwide Techniques and Outcomes in Robot-assisted Minimally Invasive Esophagectomy (RAMIE) Results From the Multicenter International Registry

B. Feike Kingma, Peter P. Grimminger, Pieter C. van der Sluis, Marc J. van Det, Ewout A. Kouwenhoven, Yin-Kai Chao, Chun-Yi Tsai, Hans F. Fuchs, Christiane J. Bruns, Inderpal S. Sarkaria, James D. Luketich, Jan W. Haveman, Boudewijn van Etten, Philip W. Chiu, Shannon M. Chan, Philippe Rouanet, Anne Mourregot, Jens-Peter Hoelzen, Rubens A. Sallum, Ivan Cecconello, Jan-Hendrik Egberts, Frank Benedix, Mark I. van Berge Henegouwen, Suzanne S. Gisbertz, Daniel Perez, Kristina Jansen, Michal Hubka, Donald E. Low, Matthias Biebl, Johann Pratschke, Paul Turner, Kish Pursnani, Asif Chaudry, Myles Smith, Elena Mazza, Paolo Strignano, Jelle P. Ruurda, Richard van Hillegersberg

Summary: This study provides an overview of the current techniques and outcomes of transthoracic RAMIE worldwide. The study found that robot-assisted hand-sewing and circular stapling had higher leakage rates, while linear stapling had lower leakage rates. The optimal approach for this procedure still needs to be further defined.

ANNALS OF SURGERY (2022)

Meeting Abstract Oncology

The Use of Indocyanine Green and Near-infrared Fluorescence Imaging versus Blue Dye in Sentinel Lymph Node Biopsy in Cutaneous Melanoma:A Retrospective Cohort Study

Michael Fadel, Sidra Rauf, Andrew Hayes, Kieran Power, Myles Smith

ANNALS OF SURGICAL ONCOLOGY (2022)

Meeting Abstract Oncology

Management of Primary Anorectal Melanoma: Experience from a Specialist Surgical Oncology Centre

Michael Fadel, Andrew Hayes, Myles Smith

ANNALS OF SURGICAL ONCOLOGY (2022)

No Data Available